Mitochon Pharmaceuticals is a clinical-stage biotech company that focuses on developing drugs targeting the mitochondria for various serious diseases with significant unmet medical needs. Their development programs primarily focus on time-sensitive insidious neurodegenerative and neuromuscular diseases, including Amyotrophic Lateral Sclerosis (ALS), Huntington’s Disease (HD), Progressive forms of Multiple Sclerosis (SPMS & P...
Mitochon Pharmaceuticals is a clinical-stage biotech company that focuses on developing drugs targeting the mitochondria for various serious diseases with significant unmet medical needs. Their development programs primarily focus on time-sensitive insidious neurodegenerative and neuromuscular diseases, including Amyotrophic Lateral Sclerosis (ALS), Huntington’s Disease (HD), Progressive forms of Multiple Sclerosis (SPMS & PPMS), Traumatic Brain Injury (TBI), Alzheimer’s Disease (AD), and Parkinson Disease (PD). The company aims to address these conditions through mitochondrial-targeted drug development.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.